How much is the Oligonucleotide Synthesis Market market?

The oligonucleotide synthesis market market size is estimated to grow at $$ 3374.04 mn in 2023. Read More

What is the growth rate of the Oligonucleotide Synthesis Market market?

The growth rate of the oligonucleotide synthesis market year-over-year is 13.54%. Read More

Which region held the largest market share in the Oligonucleotide Synthesis Market market?

North America is the region to held the largest market share with 40% growth. Read More

Who are the key players in the Oligonucleotide Synthesis Market market?

Agilent Technologies Inc., Ajinomoto Bio Pharma. , Alnylam Pharmaceuticals Inc., Amgen Inc., Ansa Biotechnologies, Bio Synthesis Inc, Biogen Inc., Biotage AB, Danaher Corp., Eurofins Scientific SE, .... Read More

Which Segment has the largest market share in the Oligonucleotide Synthesis Market market?

Application is the segment that has the largest market share in the market. Read More

Oligonucleotide Synthesis Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, China, Japan - Size and Forecast 2024-2028

Published: Apr 2024
Pages: 183
SKU: IRTNTR74336

Enjoy complimentary customisation on priority with our Enterprise License!

Oligonucleotide Synthesis Market Size 2024-2028

The oligonucleotide synthesis market size is forecast to increase by USD 3.37 billion at a CAGR of 13.54% between 2023 and 2028. The market is experiencing significant growth, driven by the increasing shift towards RNA-based therapeutics. This trend is fueled by the advancements in RNA technology and the potential of RNA therapeutics to treat various diseases, including genetic disorders and cancer. Another trend transforming the market is the integration of artificial intelligence (AI) and automation in oligonucleotide synthesis. This technology enhances efficiency, reduces errors, and lowers production costs. However, regulatory issues associated with oligonucleotide therapeutics remain a challenge. Stringent regulatory requirements and lengthy approval processes can hinder market growth. Additionally, ensuring the safety and efficacy of these therapeutics is crucial to gaining regulatory approval and market acceptance. Despite these challenges, the market is expected to continue growing, driven by the potential of oligonucleotide therapeutics to revolutionize healthcare.

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global oligonucleotide synthesis market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global oligonucleotide synthesis market 2018 - 2022 ($ million)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 PCR primers - Market size and forecast 2023-2028
- Exhibit 34: Chart on PCR primers - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on PCR primers - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on PCR primers - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on PCR primers - Year-over-year growth 2023-2028 (%)

6.4 PCR assays and panels - Market size and forecast 2023-2028
- Exhibit 38: Chart on PCR assays and panels - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on PCR assays and panels - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on PCR assays and panels - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on PCR assays and panels - Year-over-year growth 2023-2028 (%)

6.5 DNA microarrays - Market size and forecast 2023-2028
- Exhibit 42: Chart on DNA microarrays - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on DNA microarrays - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on DNA microarrays - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on DNA microarrays - Year-over-year growth 2023-2028 (%)

6.6 Fluorescence in situ hybridization - Market size and forecast 2023-2028
- Exhibit 46: Chart on Fluorescence in situ hybridization - Market size and forecast 2023-2028 ($ million)
- Exhibit 47: Data Table on Fluorescence in situ hybridization - Market size and forecast 2023-2028 ($ million)
- Exhibit 48: Chart on Fluorescence in situ hybridization - Year-over-year growth 2023-2028 (%)
- Exhibit 49: Data Table on Fluorescence in situ hybridization - Year-over-year growth 2023-2028 (%)

6.7 Sequencing and others - Market size and forecast 2023-2028
- Exhibit 50: Chart on Sequencing and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 51: Data Table on Sequencing and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 52: Chart on Sequencing and others - Year-over-year growth 2023-2028 (%)
- Exhibit 53: Data Table on Sequencing and others - Year-over-year growth 2023-2028 (%)

6.8 Market opportunity by Application
- Exhibit 54: Market opportunity by Application ($ million)
- Exhibit 55: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 56: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 57: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 58: Chart on Comparison by End-user
- Exhibit 59: Data Table on Comparison by End-user

7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
- Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)

7.4 Research and academic institutes - Market size and forecast 2023-2028
- Exhibit 64: Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
- Exhibit 65: Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
- Exhibit 66: Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%)

7.5 Diagnostic laboratories - Market size and forecast 2023-2028
- Exhibit 68: Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
- Exhibit 70: Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
- Exhibit 71: Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)

7.6 Hospitals - Market size and forecast 2023-2028
- Exhibit 72: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibit 74: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Exhibit 75: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)

7.7 Market opportunity by End-user
- Exhibit 76: Market opportunity by End-user ($ million)
- Exhibit 77: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 79: Chart on Market share by geography 2023-2028 (%)
- Exhibit 80: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 81: Chart on Geographic comparison
- Exhibit 82: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 83: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 87: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 91: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 99: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 107: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 108: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 109: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 111: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 112: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 113: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 114: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 Japan - Market size and forecast 2023-2028
- Exhibit 115: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 116: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 117: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 118: Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 119: Market opportunity by geography ($ million)
- Exhibit 120: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 121: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 122: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 123: Overview on factors of disruption

11.4 Industry risks
- Exhibit 124: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 125: Vendors covered

12.2 Market positioning of vendors
- Exhibit 126: Matrix on vendor position and classification

12.3 Agilent Technologies Inc.
- Exhibit 127: Agilent Technologies Inc. - Overview
- Exhibit 128: Agilent Technologies Inc. - Business segments
- Exhibit 129: Agilent Technologies Inc. - Key news
- Exhibit 130: Agilent Technologies Inc. - Key offerings
- Exhibit 131: Agilent Technologies Inc. - Segment focus

12.4 Ansa Biotechnologies
- Exhibit 132: Ansa Biotechnologies - Overview
- Exhibit 133: Ansa Biotechnologies - Product / Service
- Exhibit 134: Ansa Biotechnologies - Key news
- Exhibit 135: Ansa Biotechnologies - Key offerings

12.5 Biogen Inc.
- Exhibit 136: Biogen Inc. - Overview
- Exhibit 137: Biogen Inc. - Product / Service
- Exhibit 138: Biogen Inc. - Key news
- Exhibit 139: Biogen Inc. - Key offerings

12.6 Biotage AB
- Exhibit 140: Biotage AB - Overview
- Exhibit 141: Biotage AB - Product / Service
- Exhibit 142: Biotage AB - Key news
- Exhibit 143: Biotage AB - Key offerings

12.7 Danaher Corp.
- Exhibit 144: Danaher Corp. - Overview
- Exhibit 145: Danaher Corp. - Business segments
- Exhibit 146: Danaher Corp. - Key news
- Exhibit 147: Danaher Corp. - Key offerings
- Exhibit 148: Danaher Corp. - Segment focus

12.8 General Electric Co.
- Exhibit 149: General Electric Co. - Overview
- Exhibit 150: General Electric Co. - Business segments
- Exhibit 151: General Electric Co. - Key news
- Exhibit 152: General Electric Co. - Key offerings
- Exhibit 153: General Electric Co. - Segment focus

12.9 Kaneka Corp.
- Exhibit 154: Kaneka Corp. - Overview
- Exhibit 155: Kaneka Corp. - Business segments
- Exhibit 156: Kaneka Corp. - Key offerings
- Exhibit 157: Kaneka Corp. - Segment focus

12.10 LGC Science Group Holdings Ltd.
- Exhibit 158: LGC Science Group Holdings Ltd. - Overview
- Exhibit 159: LGC Science Group Holdings Ltd. - Product / Service
- Exhibit 160: LGC Science Group Holdings Ltd. - Key offerings

12.11 Merck KGaA
- Exhibit 161: Merck KGaA - Overview
- Exhibit 162: Merck KGaA - Business segments
- Exhibit 163: Merck KGaA - Key news
- Exhibit 164: Merck KGaA - Key offerings
- Exhibit 165: Merck KGaA - Segment focus

12.12 Mettler Toledo International Inc.
- Exhibit 166: Mettler Toledo International Inc. - Overview
- Exhibit 167: Mettler Toledo International Inc. - Business segments
- Exhibit 168: Mettler Toledo International Inc. - Key offerings
- Exhibit 169: Mettler Toledo International Inc. - Segment focus

12.13 QIAGEN NV
- Exhibit 170: QIAGEN NV - Overview
- Exhibit 171: QIAGEN NV - Product / Service
- Exhibit 172: QIAGEN NV - Key offerings

12.14 Sarepta Therapeutics Inc.
- Exhibit 173: Sarepta Therapeutics Inc. - Overview
- Exhibit 174: Sarepta Therapeutics Inc. - Product / Service
- Exhibit 175: Sarepta Therapeutics Inc. - Key offerings

12.15 Synbio Technologies
- Exhibit 176: Synbio Technologies - Overview
- Exhibit 177: Synbio Technologies - Product / Service
- Exhibit 178: Synbio Technologies - Key offerings

12.16 Syngene International Ltd.
- Exhibit 179: Syngene International Ltd. - Overview
- Exhibit 180: Syngene International Ltd. - Product / Service
- Exhibit 181: Syngene International Ltd. - Key offerings

12.17 Thermo Fisher Scientific Inc.
- Exhibit 182: Thermo Fisher Scientific Inc. - Overview
- Exhibit 183: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 184: Thermo Fisher Scientific Inc. - Key news
- Exhibit 185: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 186: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 187: Inclusions checklist
- Exhibit 188: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 189: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 190: Research methodology
- Exhibit 191: Validation techniques employed for market sizing
- Exhibit 192: Information sources